Literature DB >> 23307660

Retrograde cPLA2α/arachidonic acid/2-AG signaling is essential for cerebellar depolarization-induced suppression of excitation and long-term potentiation.

Li-Da Su1, De-Juan Wang, Dong Yang, Ying Shen, Ying-Hong Hu.   

Abstract

Cytosolic phospholipase A2 alpha (cPLA2α) responds to micromolar intracellular Ca(2+) and produces arachidonic acid, which regulates cellular homeostasis, neurotoxicity, and inflammation. Endocannabinoids are the derivates of arachidonic acid and widely distributed in the cerebellum. However, the role of cPLA2α/arachidonic acid pathway in cerebellar synaptic transmission and plasticity is unknown. We utilized cPLA2α knockout mice and slice whole-cell patch clamp to study the action of cPLA2α/arachidonic acid signaling on the depolarization-induced suppression of excitation (DSE) and long-term potentiation at parallel fiber-Purkinje cell synapses. Our data showed that DSE was significantly inhibited but rescued by arachidonic acid in cPLA2α knockout mice. The degradation enzyme of 2-arachidonoylglycerol (2-AG), monoacylglycerol lipase, blocked DSE, while another catabolism enzyme for N-arachidonoylethanolamine, fatty acid amide hydrolase, did not, suggesting that 2-AG is responsible for DSE in Purkinje cells. Co-application of paxilline reversed the blockade of DSE by internal K(+), indicating that large-conductance Ca(2+)-activated potassium channel is sufficient to inhibit cPLA2α/arachidonic acid-mediated DSE. On the other hand, we found that 1 Hz parallel fiber stimuli-triggered long-term potentiation (LTP) was deficient in cPLA2α knockout mice. LTP was also inhibited when AACOCF3, an inhibitor of cPLA2α, was given. Arachidonic acid was necessary for the LTP induction. Therefore, these data showed that cPLA2α/arachidonic acid/2-AG signaling pathway mediates DSE and LTP at parallel fiber-Purkinje cell synapse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307660     DOI: 10.1007/s12311-012-0444-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  15 in total

1.  A new form of cerebellar long-term potentiation is postsynaptic and depends on nitric oxide but not cAMP.

Authors:  Varda Lev-Ram; Scott T Wong; Daniel R Storm; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

2.  Endocannabinoids control the induction of cerebellar LTD.

Authors:  Patrick K Safo; Wade G Regehr
Journal:  Neuron       Date:  2005-11-23       Impact factor: 17.173

3.  A role for protein phosphatases 1, 2A, and 2B in cerebellar long-term potentiation.

Authors:  Amor Belmeguenai; Christian Hansel
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

4.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.

Authors:  J V Bonventre; Z Huang; M R Taheri; E O'Leary; E Li; M A Moskowitz; A Sapirstein
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

6.  Cytosolic phospholipase A(2) alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment.

Authors:  Ying Shen; Koji Kishimoto; David J Linden; Adam Sapirstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

Review 7.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

8.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

9.  Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease.

Authors:  Athena Kalyvas; Samuel David
Journal:  Neuron       Date:  2004-02-05       Impact factor: 17.173

Review 10.  Cannabinoid physiology and pharmacology: 30 years of progress.

Authors:  Allyn C Howlett; Christopher S Breivogel; Steven R Childers; Samuel A Deadwyler; Robert E Hampson; Linda J Porrino
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

View more
  6 in total

Review 1.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

Review 2.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

3.  cPLA2α-/- sympathetic neurons exhibit increased membrane excitability and loss of N-Type Ca2+ current inhibition by M1 muscarinic receptor signaling.

Authors:  Liwang Liu; Joseph V Bonventre; Ann R Rittenhouse
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

Review 4.  Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis.

Authors:  Nicholas B Worley; Matthew N Hill; John P Christianson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-07       Impact factor: 5.067

5.  Prostaglandin Signaling Governs Spike Timing-Dependent Plasticity at Sensory Synapses onto Mouse Spinal Projection Neurons.

Authors:  Jie Li; Elizabeth Serafin; Mark L Baccei
Journal:  J Neurosci       Date:  2018-06-22       Impact factor: 6.167

Review 6.  Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders.

Authors:  Kunio Yui; George Imataka; Hiroyuki Nakamura; Naoki Ohara; Yukiko Naito
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.